Trial · NCT06210269
Registered outcomes12
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 12 of 12
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Treatment success. | 30 days after treatment initiation | The primary outcome is 30-day treatment success defined similarly as in the previous trials, i.e. resolution of acute appendicitis resulting in discharge from the hospital without appendectomy during the 30-day follow-up. |
| Secondary | Post-intervention complications | 20 years | Complications according to the Clavien-Dindo classification |
| Secondary | Late recurrence of appendicitis | 20 years | Recurrence of acute appendicitis after the 30-day follow-up. |
| Secondary | Hospital stay | 20 years | Duration of hospital stay in hours |
| Secondary | Admission to hospital | 20 years | Admission to hospital and reason for admission, readmissions to emergency department or hospitalization. |
| Secondary | VAS score (visual analogue score) | 20 years | Pain defined by VAS pain score (scale 0-10, 0 equals no pain and 10 maximum pain imaginable) |
| Secondary | Quality of life EQ-5D-5L | 20 years | Quality of life (QOL, EQ-5D-5L). The descriptive system comprises five dimensions: mobility, self-care, usual activities, pain/discomfort and anxiety/depression. Each dimension has 5 levels: no problems, slight problems, moderate problems, severe problems and extreme problems. The patient is asked to indicate his/her health state by ticking the box next to the most appropriate statement in each of the five dimensions. This decision results in a 1-digit number that expresses the level selected for that dimension. The digits for the five dimensions can be combined into a 5-digit number that describes the patient's health state. |
| Secondary | Sick leave | 20 years | Duration of sick leave in days |
| Secondary | Treatment costs | 20 years | Overall treatment and societal costs. |
| Secondary | Prognostic factors predicting initial unresponsiveness or recurrent appendicitis | 20 years | Potential prognostic factors predicting initial unresponsiveness to the randomized treatment as well as recurrent appendicitis |
| Secondary | True appendicitis recurrence | 20 years | True appendicitis recurrence rate following initial successful non-operative treatment as well as the final clinical diagnosis for all operated patients will be evaluated based on the intraoperative and histopathological findings |
| Secondary | Subgroup analysis of eligible, not randomized patients | 5 years | Subgroup analysis of eligible, not randomized patients on all secondary outcomes. |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT06210269/registered